PATENT CLAIM ANALYSIS

Application Number: 16143682
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["600", "476000"]

Abstract:
In certain aspects, the invention relates to processes for using renally excretable optical agents to detect one or more tissues of the renal system of a surgical patient. In certain aspects, the invention relates to a kit including a biocompatible composition containing one or more optical agents and instructions for using the optical agent(s) in a process of the present invention.

Claim (Index 27):
The process of  claim 25 , wherein the pyrazine molecule of Formula 7 is selected from the group consisting of 3,6-dicyano-2,5-[(N,N,N\u2032,N\u2032-tetrakis(carboxymethyl)aminolpyrazine, 3,6-[(N,N,N\u2032,N\u2032-tetrakis(2-hydroxyethyl)amino]pyrazine-2,5-dicarboxylic acid, 3,6-bis(N-azatedino)pyrazine-2,5-dicarboxylic acid, 3,6-bis(N-morpholino)pyrazine-2,5-dicarboxylic acid, 3,6-bis(N-piperazino)pyrazine-2,5-dicarboxylic acid, 3,6-bis(N-thiomorpholino)pyrazine-2,5-dicarboxylic acid, 3,6-bis(N-thiomorpholino)pyrazine-2,5-dicarboxylic acid S-oxide, 2,5-dicyano-3,6-bis(N-thiomorpholino)pyrazine S,S-dioxide, 3,6-diaminopyrazine-2,5-dicarboxylic acid, and pharmaceutically acceptable formulation thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 1.65854
- Patent Class: 600.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14919967', '11995270', '11721186', '14047733', '15178720']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5533126966888493
- 35 USC 102 Novelty (BERT): 0.5701505448092699
- Combined Prediction Score: 0.5549964815008914
- Mean Citation Score: 332.918408
- Max Citation Score: 571.0967400000002
- Similarity Product: 373.94737013568175

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test